MDMA-assisted Massed Prolonged Exposure for PTSD

Phase: PHASE3 | Sponsor: Healing Breakthrough | Compound: MDMA

Status

recruiting

Institution

Healing Breakthrough

Start date

2024-10-25

End date

2026-01-01

Registry ID

NCT06117306

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.